Introduction. We report a two centre experience with a depopulated ureteric xenograft (SGVG 100((R)), CryoLife Inc., GA, USA) for femoropopliteal revascularization in 12 patients with chronic critical limb ischemia. Report. Between 7 days and 18 months after implantation, 10 of 12 patients (1 lost to follow-up) had the graft explanted due to aneurysmal enlargement. At 5 years, only one graft was still patent and showed moderate signs of enlargement. Conclusion. The SGVG 100((R)) is not a safe conduit for femoropopliteal bypass surgery.
Tolva, V., Bertoni, G., Trimarchi, S., Grassi, V., Fusari, M., Rampoldi, V. (2007). Unreliability of depopulated bovine ureteric xenograft for infra inguinal bypass surgery: mid-term results from two vascular centres. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 33(2), 214-216 [10.1016/j.ejvs.2006.10.007].
Unreliability of depopulated bovine ureteric xenograft for infra inguinal bypass surgery: mid-term results from two vascular centres
TOLVA, VALERIO STEFANO;
2007
Abstract
Introduction. We report a two centre experience with a depopulated ureteric xenograft (SGVG 100((R)), CryoLife Inc., GA, USA) for femoropopliteal revascularization in 12 patients with chronic critical limb ischemia. Report. Between 7 days and 18 months after implantation, 10 of 12 patients (1 lost to follow-up) had the graft explanted due to aneurysmal enlargement. At 5 years, only one graft was still patent and showed moderate signs of enlargement. Conclusion. The SGVG 100((R)) is not a safe conduit for femoropopliteal bypass surgery.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
